Diabetologia, Diabetes, Cardiovascular Risks, and Lipoproteins
In diabetes, cardiovascular risks, and lipoproteins
Charles
Agyemang
Scholar“Research focused on Diabetes, Cardiovascular Risks, and Lipoproteins and adjacent fields.”
66
H-index
16.0k
Citations
Charles has not officially claimed their profile. If you are Charles, claim it free.
Claim Your Profile
Pioneer
LOCKED

Pathfinder
LOCKED

Scholar
EARNED

Innovator
LOCKED

Inventor
LOCKED

Catalyst
LOCKED

Expert
UPGRADE
What I study
harles Agyemang is a researcher working on Diabetes, Cardiovascular Risks, and Lipoproteins. A fuller summary will appear once they update their profile.
Publication output and reach
Charles's work has been cited 16,035 times across 4 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
Topics
Recent publications
16 worksCommunications Medicine, Global Health and Surgery
Diabetologia, Epigenetics and DNA Methylation
The Lancet Diabetes & Endocrinology, Diabetes, Cardiovascular Risks, and Lipoproteins
Critical Public Health, Physical Activity and Health
European Heart Journal Supplements, Blood Pressure and Hypertension Studies
European Journal of Public Health, Global Public Health Policies and Epidemiology
Clinical Epigenetics, Epigenetics and DNA Methylation
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Charles?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Free to claim · takes a minute to verify it’s you